SCHEMBL20133017

SCHEMBL20133017

CC[C@@H](C(=O)N1C[C@H](OCc2cc([C@@H](CC)C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)on2)C[C@H]1C(=O)NCc1ccc(-c2ocnc2C)cc1)c1cc(CO[C@@H]2C[C@@H](C(=O)N[C@@H](C)c3ccc(-c4cncs4)cc3)N(C(=O)[C@H](CC)c3cc(C)no3)C2)no1

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ VHL P40337 20/20 0.64
▸ ELOC Q15369 7/20 0.49
▸ ELOB Q15370 7/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762052 0.92 VHL (0.52) VHLELOCELOB
SCHEMBL20330246 0.92 VHL (0.76) VHLELOCELOB
SCHEMBL20329986 0.89 VHL (0.72) VHLELOCELOB
SCHEMBL23664702 0.89 VHL (0.58) VHLELOCELOB
SCHEMBL21673523 0.89 VHL (0.58) VHLELOCELOB
SCHEMBL20330145 0.89 VHL (0.57) VHLELOCELOB
SCHEMBL24762073 0.88 VHL (0.57) VHLELOCELOB
SCHEMBL21906771 0.88 VHL (0.70) VHLELOCELOB
SCHEMBL26026759 0.87 VHL (0.63) VHLELOCELOB
SCHEMBL20330143 0.87 VHL (0.53) VHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. 2018-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180125821-A1 TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE CRBN, VHL, UBQLN2 VHL 2/4885ELOC 414/4885ELOB 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback